Literature DB >> 9540053

Expression of annexin II in glioma cell lines and in brain tumor biopsies.

S J Nygaard1, H K Haugland, E K Kristoffersen, M Lund-Johansen, O D Laerum, O B Tysnes.   

Abstract

Annexin II is a calcium and phospholipid binding protein and a substrate for protein-tyrosine kinases. Increased levels of annexin II are observed in various cancer cells and tissues, and the molecule has been proposed as a marker of malignancy in vivo. Annexin II was expressed in four glioma cell lines (D-54MG, D-37MG, U251MG and GaMG), as determined by Western blot analyses, immunofluorescence staining and flow cytometric measurements. In addition, annexin II expression was also found in cryostat sections obtained from 15 consecutive brain tumor biopsies: Ten were histologically classified as glioblastomas, one as an astrocytoma, two as meningiomas and two as brain metastases. Cultured spheroids from the glioma cell lines and from three of the glioblastoma biopsies showed lower levels of annexin II, than found in the monolayers of the cell lines and in the freshly cut biopsies. The annexin II expression of the cell lines were not found to be related to their proliferative, migratory or invasive properties. These findings indicate that although annexin II may serve as a marker of malignancy in vivo, its expression can be reduced in vitro, and appear unrelated to malignant features of glioma cell lines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9540053     DOI: 10.1023/a:1005953000523

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

1.  In vivo modulation of annexins I, II and V expression by thyroxine and methylthiouracil.

Authors:  H el Btaouri; D Claisse; G Bellon; F Antonicelli; B Haye
Journal:  Eur J Biochem       Date:  1996-12-15

2.  Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo.

Authors:  R Bjerkvig; O D Laerum; O Mella
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Invasive glioma cells in tissue culture.

Authors:  M Lund-Johansen; O Engebraaten; R Bjerkvig; O D Laerum
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

5.  Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation.

Authors:  M Perretti; R J Flower
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 6.  Patterns of antigenic expression of human glioma cells.

Authors:  P E McKeever; R D Davenport; P Shakui
Journal:  Crit Rev Neurobiol       Date:  1991

7.  Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma.

Authors:  S A Reeves; C Chavez-Kappel; R Davis; M Rosenblum; M A Israel
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

Review 8.  Protein kinase C and growth regulation of malignant gliomas.

Authors:  G H Baltuch; N P Dooley; J G Villemure; V W Yong
Journal:  Can J Neurol Sci       Date:  1995-11       Impact factor: 2.104

9.  Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas.

Authors:  S H Torp; E Helseth; A Dalen; G Unsgaard
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

10.  Annexin II marks astrocytic brain tumors of high histologic grade.

Authors:  B J Roseman; A Bollen; J Hsu; K Lamborn; M A Israel
Journal:  Oncol Res       Date:  1994       Impact factor: 5.574

View more
  14 in total

1.  Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.

Authors:  Shu-Hsiang Liu; Chiao-Ying Lin; Shian-Yang Peng; Yung-Ming Jeng; Hung-Wei Pan; Po-Lin Lai; Chao-Lien Liu; Hey-Chi Hsu
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

2.  The role of annexin A2 in tumorigenesis and cancer progression.

Authors:  Noor A Lokman; Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Cancer Microenviron       Date:  2011-03-05

3.  Annexin A2 promotes glioma cell invasion and tumor progression.

Authors:  Haiyan Zhai; Suchitra Acharya; Iordanis Gravanis; Saira Mehmood; Roberta J Seidman; Kenneth R Shroyer; Katherine A Hajjar; Stella E Tsirka
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

4.  Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

Authors:  Kamala Kesavan; Judson Ratliff; Eric W Johnson; William Dahlberg; John M Asara; Preeti Misra; John V Frangioni; Douglas B Jacoby
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

5.  Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome.

Authors:  U Zimmermann; C Woenckhaus; S Pietschmann; H Junker; S Maile; K Schultz; C Protzel; J Giebel
Journal:  Virchows Arch       Date:  2004-08-26       Impact factor: 4.064

Review 6.  Annexin A2 system in human biology: cell surface and beyond.

Authors:  Min Luo; Katherine A Hajjar
Journal:  Semin Thromb Hemost       Date:  2013-03-12       Impact factor: 4.180

7.  Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.

Authors:  Chi-Yun Wang; Chia-Ling Chen; Yau-Lin Tseng; Yi-Ting Fang; Yee-Shin Lin; Wu-Chou Su; Chien-Chin Chen; Kung-Chao Chang; Yi-Ching Wang; Chiou-Feng Lin
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

8.  tPA receptors and the fibrinolytic response in multiple sclerosis lesions.

Authors:  Djordje Gveric; Blanca M Herrera; M Louise Cuzner
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 9.  The annexin A2/S100A10 system in health and disease: emerging paradigms.

Authors:  Nadia Hedhli; Domenick J Falcone; Bihui Huang; Gabriela Cesarman-Maus; Rosemary Kraemer; Haiyan Zhai; Stella E Tsirka; Laura Santambrogio; Katherine A Hajjar
Journal:  J Biomed Biotechnol       Date:  2012-10-14

10.  Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II.

Authors:  Jie Liu; Christy A Rothermund; Jesus Ayala-Sanmartin; Jamboor K Vishwanatha
Journal:  BMC Biochem       Date:  2003-09-09       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.